Xenon Pharmaceuticals
XENE
XENE
103 hedge funds and large institutions have $671M invested in Xenon Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 91 → 103 (+12)
0.2% less ownership
Funds ownership: 82.14% → 81.94% (-0.2%)
6% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 31
Holders
103
Holding in Top 10
6
Calls
$3.86M
Puts
$652K
Top Buyers
| 1 | +$51.4M | |
| 2 | +$21.7M | |
| 3 | +$16M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$15.3M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$13.3M |
Top Sellers
| 1 | -$35.6M | |
| 2 | -$21.7M | |
| 3 | -$19.1M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$8.83M |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$1.25M |